Start Trading Now Get Started

Humana (NYSE:HUM) Stock Signal: Should You Buy the Earnings Beat?

By Adam Lemon
Chief Analyst and Director of Content

Adam Lemon began his role at DailyForex in 2013 when he was brought in as an in-house Chief Analyst. Adam trades Forex, stocks and other instruments in his own account. Adam believes that it is very possible for retail traders/investors to secure a positive return over time provided they limit their risks, follow trends, and persevere through short-term losing streaks – provided only reputable brokerages are used. He has previously worked with...

Read more

Long Trade Idea

Enter your long position between $244.55 (an intermediate horizontal support level) and $251.78 (yesterday’s intra-day high).

Market Index Analysis

  • Humana (NYSE:HUM) is a member of the S&P 500 Index.

  • This index records all-time highs despite worsening macroeconomic issues.

  • The Bull Bear Power Indicator for the S&P 500 Index is bullish with a negative divergence.

Market Sentiment Analysis

Equity futures are moving higher and extending their record run amid optimism over tech earnings, but ARM Holdings sent jitters through markets amid chip supply concerns, while monitoring progress in the US-Iran peace process and ignoring macroeconomic issues from higher-for-longer oil prices, troubling consumer credit developments with auto loans the latest flashpoint, and market stability risks from private credit. Earnings from McDonald’s, Shake Shack, and Papa John’s will offer more consumer spending insights today.

Humana Fundamental Analysis

Humana is a health insurance company, the highest-ranked Kentucky company by revenues, and the fourth-largest US health insurance provider. It also manages TRICARE, a health care program of the US Department of Defense.

So, why am I bullish on HUM amid its post-earnings rally?

Humana beat revenue and earnings-per-share expectations of $39.7 billion and $10.25, respectively, reporting $39.65 billion and $10.31 per share. I remain bullish on Humana, driven by its expected 25% year-over-year increase in individual Medicare Advantage (MA) memberships, which could potentially make it the largest MA insurer in the US. I am equally bullish on the expansion of its CenterWell primary care platform and on margin expansion driven by its operational focus on efficiency, centralized transformation, and medical cost management.

Metric
Value
Verdict
P/E Ratio
26.32
Bullish
P/B Ratio
1.59
Bullish
PEG Ratio
1.40
Bullish
Current Ratio
1.77
Bearish
ROIC-WACC Ratio
Positive
Bullish

Humana Fundamental Analysis Snapshot

The price-to-earning (P/E) ratio of 26.32 makes HUM an inexpensive stock. By comparison, the P/E ratio for the S&P 500 Index is 31.66.

The average analyst price target for HUM is $240.50. This suggests no upside potential, but I see price action moving toward the high end of estimates at $333.00, while downside risks remain reasonable.

Humana Technical Analysis

Today’s HUM Signal

HUM050726

Humana Price Chart

  • The HUM D1 chart shows price action inside a bullish price channel.

  • It also shows price action breaking out above its descending Fibonacci Retracement Fan.

  • The Bull Bear Power Indicator is bullish with a negative divergence, suggesting more short-term volatility potential.

  • The average bullish trading volumes are higher than the average bearish trading volumes.

  • HUM advanced more than the S&P 500 Index, a significant bullish confirmation.

My HUM Long Stock Trade

  • HUM Entry Level: Between $244.55 and $251.78

  • HUM Take Profit: Between $315.35 and $324.18

  • HUM Stop Loss: Between $210.59 and $216.49

  • Risk/Reward Ratio: 2.09

Ready to trade our analysis of Humana? Here is our list of the best stockbrokers worth checking out.

Chief Analyst and Director of Content

Adam Lemon began his role at DailyForex in 2013 when he was brought in as an in-house Chief Analyst. Adam trades Forex, stocks and other instruments in his own account. Adam believes that it is very possible for retail traders/investors to secure a positive return over time provided they limit their risks, follow trends, and persevere through short-term losing streaks – provided only reputable brokerages are used. He has previously worked within financial markets over a 12-year period, including 6 years with Merrill Lynch.

Most Visited Forex Broker Reviews